{"source":"https://secwatch.observer","license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","next_cursor":"2026-05-26T12:30:22+00:00|650037","filings":[{"accession":"0001661458-26-000021","headline":"Highlands REIT fails quorum at annual meeting; 219.7M of 722.2M shares present, meeting adjourned","bullets":["Only 219,744,634 of 722,202,902 outstanding shares represented, failing the majority quorum requirement.","No business conducted; meeting adjourned and not expected to reconvene.","Current directors Jeffrey L. Shekell, R. David Turner, and Robert J. Lange continue in office.","Proxy submissions indicated ~88% support for each director nominee, but no votes were cast.","Ratification of Grant Thornton as auditor had 208.5M for and 6.9M against among proxies."],"event_type":"other_material","confidence":"high","sentiment":"neutral","materiality_score":0.4,"ticker":null,"company_name":"Highlands REIT, Inc.","filed_at":"2026-05-26T18:23:17+00:00","last_material_update_at":"2026-05-26T18:25:39.038604+00:00","item_codes":["8.01"],"url":"https://secwatch.observer/filing/0001661458-26-000021","json_url":"https://secwatch.observer/filing/0001661458-26-000021.json","markdown_url":"https://secwatch.observer/filing/0001661458-26-000021.md","summary_text_url":"https://secwatch.observer/filing/0001661458-26-000021.txt","source_url":"https://www.sec.gov/Archives/edgar/data/1661458/000166145826000021/0001661458-26-000021-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/1661458/000166145826000021/hri-20260522.htm"},{"accession":"0001193125-26-238654","headline":"Apollo Infra reports April NAV $1.93B; issues ~$34.6M unregistered shares","bullets":["Total NAV as of April 30, 2026: $1,928,062,000; NAV per share ranges $27.87 to $29.30 across classes.","Unregistered sales in May 2026: ~$34.6M cash from Series I and Series II share issuances (various classes).","Investments at fair value $1,850,288K (cost $1,695,014K); cash $115,494K; net other liabilities $39,445K.","Over 67.3M shares outstanding; detailed per-class NAV disclosed for Series I and Series II."],"event_type":"other_material","confidence":"high","sentiment":"neutral","materiality_score":0.6,"ticker":null,"company_name":"Apollo Infrastructure Co LLC","filed_at":"2026-05-26T18:19:04+00:00","last_material_update_at":"2026-05-26T18:21:07.403907+00:00","item_codes":["3.02","8.01","9.01"],"url":"https://secwatch.observer/filing/0001193125-26-238654","json_url":"https://secwatch.observer/filing/0001193125-26-238654.json","markdown_url":"https://secwatch.observer/filing/0001193125-26-238654.md","summary_text_url":"https://secwatch.observer/filing/0001193125-26-238654.txt","source_url":"https://www.sec.gov/Archives/edgar/data/1971381/000119312526238654/0001193125-26-238654-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/1971381/000119312526238654/ck0001971381-20260526.htm"},{"accession":"0001493152-26-025217","headline":"InterGroup shareholders elect two directors, ratify auditor at 2026 annual meeting","bullets":["Yvonne L. Murphy elected as Class B director with 1,517,016 votes for, 1,253 withheld, 181,799 broker non-votes.","William J. Nance elected as Class B director with 1,514,496 votes for, 3,773 withheld, 181,799 broker non-votes.","Whitley Penn LLP ratified as independent auditor for FY2026: 1,694,002 for, 5,571 against, 495 abstain; no broker non-votes.","Annual meeting held on May 20, 2026; all proposals passed without material opposition."],"event_type":"other","confidence":"high","sentiment":"neutral","materiality_score":0.25,"ticker":"INTG","company_name":"INTERGROUP CORP","filed_at":"2026-05-26T18:12:18+00:00","last_material_update_at":"2026-05-26T18:14:30.806723+00:00","item_codes":["5.07"],"url":"https://secwatch.observer/filing/0001493152-26-025217","json_url":"https://secwatch.observer/filing/0001493152-26-025217.json","markdown_url":"https://secwatch.observer/filing/0001493152-26-025217.md","summary_text_url":"https://secwatch.observer/filing/0001493152-26-025217.txt","source_url":"https://www.sec.gov/Archives/edgar/data/69422/000149315226025217/0001493152-26-025217-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/69422/000149315226025217/form8-k.htm"},{"accession":"0001493152-26-025218","headline":"Portsmouth Square shareholders elect directors, ratify auditor at annual meeting","bullets":["Directors elected: John V. Winfield, William J. Nance, Yvonne L. Murphy, Steve Grunwald, Andrew J. Kaplan; each received >593,000 for votes with ~28,000 broker non-votes.","Ratification of Whitley Penn LLP as independent auditor for FY2026 approved: 611,467 for, 182 against, 12,818 abstain, no broker non-votes.","Annual meeting held May 20, 2026 at Hilton San Francisco Financial District."],"event_type":"other","confidence":"high","sentiment":"neutral","materiality_score":0.1,"ticker":"PRSI","company_name":"PORTSMOUTH SQUARE INC","filed_at":"2026-05-26T18:12:18+00:00","last_material_update_at":"2026-05-26T18:13:20.691830+00:00","item_codes":["5.07"],"url":"https://secwatch.observer/filing/0001493152-26-025218","json_url":"https://secwatch.observer/filing/0001493152-26-025218.json","markdown_url":"https://secwatch.observer/filing/0001493152-26-025218.md","summary_text_url":"https://secwatch.observer/filing/0001493152-26-025218.txt","source_url":"https://www.sec.gov/Archives/edgar/data/79661/000149315226025218/0001493152-26-025218-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/79661/000149315226025218/form8-k.htm"},{"accession":"0001193125-26-238623","headline":"CBL shareholders elect all 7 directors, ratify Deloitte, approve say-on-pay","bullets":["All seven director nominees elected; votes for ranged from 23.8M to 25.2M; broker non-votes ~1.58M.","Ratification of Deloitte & Touche as FY2026 auditor: 26.4M for, 458k against, 17.6k abstain.","Advisory approval of executive compensation: 22.8M for, 347k against, 2.2M abstain, 1.58M broker non-votes."],"event_type":"other","confidence":"high","sentiment":"neutral","materiality_score":0.2,"ticker":"CBL","company_name":"CBL & ASSOCIATES PROPERTIES INC","filed_at":"2026-05-26T18:09:40+00:00","last_material_update_at":"2026-05-26T18:12:09.586696+00:00","item_codes":["5.07"],"url":"https://secwatch.observer/filing/0001193125-26-238623","json_url":"https://secwatch.observer/filing/0001193125-26-238623.json","markdown_url":"https://secwatch.observer/filing/0001193125-26-238623.md","summary_text_url":"https://secwatch.observer/filing/0001193125-26-238623.txt","source_url":"https://www.sec.gov/Archives/edgar/data/910612/000119312526238623/0001193125-26-238623-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/910612/000119312526238623/cbl-20260521.htm"},{"accession":"0001907982-26-000071","headline":"D-Wave says quantum supremacy result stands; Flatiron work does not reproduce hardest cases","bullets":["Company states recent classical simulation work from Flatiron Institute does not overturn its peer-reviewed Science result.","CEO Alan Baratz says full scope of demonstration, including hardest cases and measurements, has not been reproduced.","CDO Trevor Lanting notes BP-TNS algorithm fails for strongly coupled 3D spin glasses and biclique problems.","Original Science paper showed matching quantum simulation quality would require nearly 1M years on Frontier supercomputer.","D-Wave encourages classical progress but distinguishes meaningful advance from overturning a quantum supremacy claim."],"event_type":"other_material","confidence":"high","sentiment":"positive","materiality_score":0.65,"ticker":"QBTS","company_name":"D-Wave Quantum Inc.","filed_at":"2026-05-26T18:01:21+00:00","last_material_update_at":"2026-05-26T18:02:51.804591+00:00","item_codes":["7.01","9.01"],"url":"https://secwatch.observer/filing/0001907982-26-000071","json_url":"https://secwatch.observer/filing/0001907982-26-000071.json","markdown_url":"https://secwatch.observer/filing/0001907982-26-000071.md","summary_text_url":"https://secwatch.observer/filing/0001907982-26-000071.txt","source_url":"https://www.sec.gov/Archives/edgar/data/1907982/000190798226000071/0001907982-26-000071-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/1907982/000190798226000071/qbts-20260526.htm"},{"accession":"0001562762-26-000069","headline":"Cato Q1 net income $9.3M ($0.47 EPS) vs $3.3M last year; same-store sales +3%","bullets":["Net income $9.3M ($0.47 diluted EPS) vs $3.3M ($0.17) prior-year Q1; revenue $169.5M (+0.7%).","Same-store sales up 3%; gross margin 37.2% (35.1%) boosted by $5.7M pre-tax IEEPA tariff refund claim.","Company repurchased 107,823 shares during the quarter; store count 1,065 (down 44 YoY).","Shareholders re-elected three directors, approved executive compensation, and ratified PwC as auditor."],"event_type":"earnings","confidence":"high","sentiment":"positive","materiality_score":0.65,"ticker":"CATO","company_name":"CATO CORP","filed_at":"2026-05-26T18:00:21+00:00","last_material_update_at":"2026-05-26T18:03:52.974902+00:00","item_codes":["2.02","5.07","9.01"],"url":"https://secwatch.observer/filing/0001562762-26-000069","json_url":"https://secwatch.observer/filing/0001562762-26-000069.json","markdown_url":"https://secwatch.observer/filing/0001562762-26-000069.md","summary_text_url":"https://secwatch.observer/filing/0001562762-26-000069.txt","source_url":"https://www.sec.gov/Archives/edgar/data/18255/000156276226000069/0001562762-26-000069-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/18255/000156276226000069/cato-20260521.htm"},{"accession":"0001114927-26-000070","headline":"First Northern shareholders elect all 11 directors, approve say-on-pay, ratify Baker Tilly","bullets":["Each of 11 director nominees received >9.5M votes for; broker non-votes ~1.95M per nominee.","Advisory say-on-pay approved: 9,144,400 for, 107,971 against, 165,180 abstain, 2,136,864 broker non-votes.","Ratification of Baker Tilly as auditor for 2026: 11,433,489 for, 15,344 against, 105,582 abstain.","All proposals passed at May 19, 2026 Annual Meeting."],"event_type":"other_material","confidence":"high","sentiment":"neutral","materiality_score":0.3,"ticker":"FNRN","company_name":"FIRST NORTHERN COMMUNITY BANCORP","filed_at":"2026-05-26T17:59:13+00:00","last_material_update_at":"2026-05-26T18:00:55.865103+00:00","item_codes":["5.07"],"url":"https://secwatch.observer/filing/0001114927-26-000070","json_url":"https://secwatch.observer/filing/0001114927-26-000070.json","markdown_url":"https://secwatch.observer/filing/0001114927-26-000070.md","summary_text_url":"https://secwatch.observer/filing/0001114927-26-000070.txt","source_url":"https://www.sec.gov/Archives/edgar/data/1114927/000111492726000070/0001114927-26-000070-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/1114927/000111492726000070/form8_k.htm"},{"accession":"0001037868-26-000163","headline":"AMETEK completes acquisition of First Aviation Services; ~$80M revenue","bullets":["First Aviation Services generates ~$80M in annual revenue and operates six U.S. centers of excellence.","First Aviation provides MRO for advanced electronics, rotor blades, propellers, landing gear, and flight controls.","Acquisition is a strategic fit, expanding AMETEK's MRO capabilities in defense and aerospace.","First Aviation joins AMETEK's Electromechanical Group (EMG).","CEO David Zapico welcomes team, cites opportunities for market expansion and added scale."],"event_type":"m_and_a","confidence":"high","sentiment":"positive","materiality_score":0.65,"ticker":"AME","company_name":"AMETEK INC/","filed_at":"2026-05-26T17:38:25+00:00","last_material_update_at":"2026-05-26T17:39:19.144151+00:00","item_codes":["8.01","9.01"],"url":"https://secwatch.observer/filing/0001037868-26-000163","json_url":"https://secwatch.observer/filing/0001037868-26-000163.json","markdown_url":"https://secwatch.observer/filing/0001037868-26-000163.md","summary_text_url":"https://secwatch.observer/filing/0001037868-26-000163.txt","source_url":"https://www.sec.gov/Archives/edgar/data/1037868/000103786826000163/0001037868-26-000163-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/1037868/000103786826000163/ame-20260526.htm"},{"accession":"0001628280-26-037995","headline":"Edgewell Personal Care replaces Chief Supply Chain Officer; Hibbert out, Freve in","bullets":["Paul R. Hibbert will cease as Chief Supply Chain Officer effective June 1, 2026; eligible for Executive Severance Plan.","Anthony Freve appointed as Chief Supply Chain Officer, also effective June 1, 2026.","Company thanks Hibbert for his contributions; no reason for departure stated."],"event_type":"leadership","confidence":"high","sentiment":"neutral","materiality_score":0.5,"ticker":"EPC","company_name":"EDGEWELL PERSONAL CARE Co","filed_at":"2026-05-26T17:19:14+00:00","last_material_update_at":"2026-05-26T17:20:12.607268+00:00","item_codes":["5.02","7.01","9.01"],"url":"https://secwatch.observer/filing/0001628280-26-037995","json_url":"https://secwatch.observer/filing/0001628280-26-037995.json","markdown_url":"https://secwatch.observer/filing/0001628280-26-037995.md","summary_text_url":"https://secwatch.observer/filing/0001628280-26-037995.txt","source_url":"https://www.sec.gov/Archives/edgar/data/1096752/000162828026037995/0001628280-26-037995-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/1096752/000162828026037995/epc-20260520.htm"},{"accession":"0000943374-26-000211","headline":"Provident Financial amends Executive Chairman Martin's agreement through May 2028, adds Director Emeritus role","bullets":["Amended Executive Chairman Agreement extends term to May 21, 2028, superseding prior 2021 agreement.","Upon term end or board departure, Martin serves as Director Emeritus of Provident Bank for three years.","Amended Change in Control Agreement sets severance equal to remaining days in term divided by 365 times average annual compensation.","Base salary floor remains $577,500; all other compensation and benefits substantially unchanged.","Agreements dated May 21, 2026, and filed as Exhibits 10.1 and 10.2."],"event_type":"other_material","confidence":"high","sentiment":"neutral","materiality_score":0.5,"ticker":"PFS","company_name":"PROVIDENT FINANCIAL SERVICES INC","filed_at":"2026-05-26T16:37:48+00:00","last_material_update_at":"2026-05-26T16:39:52.949285+00:00","item_codes":["5.02","9.01"],"url":"https://secwatch.observer/filing/0000943374-26-000211","json_url":"https://secwatch.observer/filing/0000943374-26-000211.json","markdown_url":"https://secwatch.observer/filing/0000943374-26-000211.md","summary_text_url":"https://secwatch.observer/filing/0000943374-26-000211.txt","source_url":"https://www.sec.gov/Archives/edgar/data/1178970/000094337426000211/0000943374-26-000211-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/1178970/000094337426000211/form8k_052126.htm"},{"accession":"0001331757-26-000098","headline":"FHLB Dallas issues $500M in callable consolidated bonds at 3.887% and 3.830%","bullets":["Issued $250M bond due 2/23/2027, coupon 3.887%, European call on 11/23/2026.","Issued $250M bond due 11/20/2026, coupon 3.830%, Bermudan call starting 8/20/2026.","Bonds are joint and several obligations of all 11 FHLBs, not U.S. government guaranteed.","Proceeds will be used for general funding; discount notes under 1 year not reported."],"event_type":"debt","confidence":"high","sentiment":"neutral","materiality_score":0.4,"ticker":null,"company_name":"Federal Home Loan Bank of Dallas","filed_at":"2026-05-26T16:31:41+00:00","last_material_update_at":"2026-05-26T16:33:16.498575+00:00","item_codes":["2.03"],"url":"https://secwatch.observer/filing/0001331757-26-000098","json_url":"https://secwatch.observer/filing/0001331757-26-000098.json","markdown_url":"https://secwatch.observer/filing/0001331757-26-000098.md","summary_text_url":"https://secwatch.observer/filing/0001331757-26-000098.txt","source_url":"https://www.sec.gov/Archives/edgar/data/1331757/000133175726000098/0001331757-26-000098-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/1331757/000133175726000098/fhlbd-20260520.htm"},{"accession":"0001193125-26-238356","headline":"Velocity Financial shareholders re-elect all 8 directors, approve say-on-pay, ratify RSM US LLP as auditor","bullets":["All 8 director nominees re-elected; e.g., Dorika M. Beckett received 24,668,443 For, 12,440 Against.","Advisory vote on named executive officer compensation approved: 24,590,950 For, 92,104 Against.","Ratification of RSM US LLP as 2026 independent auditor passed: 25,860,650 For, 2,294 Against, 6,528 Abstain.","Meeting held May 21, 2026; results filed May 26, 2026."],"event_type":"other","confidence":"high","sentiment":"neutral","materiality_score":0.25,"ticker":"VEL","company_name":"Velocity Financial, Inc.","filed_at":"2026-05-26T16:15:04+00:00","last_material_update_at":"2026-05-26T16:18:18.223599+00:00","item_codes":["5.07","9.01"],"url":"https://secwatch.observer/filing/0001193125-26-238356","json_url":"https://secwatch.observer/filing/0001193125-26-238356.json","markdown_url":"https://secwatch.observer/filing/0001193125-26-238356.md","summary_text_url":"https://secwatch.observer/filing/0001193125-26-238356.txt","source_url":"https://www.sec.gov/Archives/edgar/data/1692376/000119312526238356/0001193125-26-238356-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/1692376/000119312526238356/d293955d8k.htm"},{"accession":"0001679273-26-000018","headline":"Lamb Weston Chinese sub refinances with RMB 700M term loan due 2031","bullets":["New RMB 700M (~$102.9M) term loan with HSBC-led syndicate, matures May 22, 2031.","Proceeds refinance existing 2022 facility, which was repaid and terminated on May 22, 2026.","Interest at 5-year LPR plus 0.30%; bi-annual amortization starting 6 months after draw.","Loan is unconditionally guaranteed by Lamb Weston Holdings (LW).","Standard PRC covenants and acceleration triggers, including cross-default to LW's senior credit facility."],"event_type":"debt","confidence":"high","sentiment":"neutral","materiality_score":0.5,"ticker":"LW","company_name":"Lamb Weston Holdings, Inc.","filed_at":"2026-05-26T15:36:37+00:00","last_material_update_at":"2026-05-26T15:40:31.980722+00:00","item_codes":["1.01","1.02","2.03","9.01"],"url":"https://secwatch.observer/filing/0001679273-26-000018","json_url":"https://secwatch.observer/filing/0001679273-26-000018.json","markdown_url":"https://secwatch.observer/filing/0001679273-26-000018.md","summary_text_url":"https://secwatch.observer/filing/0001679273-26-000018.txt","source_url":"https://www.sec.gov/Archives/edgar/data/1679273/000167927326000018/0001679273-26-000018-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/1679273/000167927326000018/lw-20260519.htm"},{"accession":"0001437749-26-018331","headline":"Zion Oil & Gas founder and Executive Chairman John Brown dies at 86; succession plan in place","bullets":["John Brown passed away peacefully at home on May 22, 2026 at age 86; memorial services set for May 28.","Brown had planned to retire as Executive Chairman at the annual shareholder meeting on June 2, 2026.","Succession led by CEO Robert W. A. Dunn and President/CFO Michael B. Croswell, both approximately 50 years old.","Company reaffirms commitment to pursue oil and gas exploration in Israel as per Brown's vision."],"event_type":"leadership","confidence":"high","sentiment":"neutral","materiality_score":0.6,"ticker":"ZNOG","company_name":"ZION OIL & GAS INC","filed_at":"2026-05-26T15:21:23+00:00","last_material_update_at":"2026-05-26T15:23:17.962884+00:00","item_codes":["5.02","9.01"],"url":"https://secwatch.observer/filing/0001437749-26-018331","json_url":"https://secwatch.observer/filing/0001437749-26-018331.json","markdown_url":"https://secwatch.observer/filing/0001437749-26-018331.md","summary_text_url":"https://secwatch.observer/filing/0001437749-26-018331.txt","source_url":"https://www.sec.gov/Archives/edgar/data/1131312/000143774926018331/0001437749-26-018331-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/1131312/000143774926018331/znog20260525_8k.htm"},{"accession":"0001999371-26-011418","headline":"Tompkins Financial shareholders elect all 11 directors, approve say-on-pay, ratify KPMG","bullets":["All 11 director nominees elected with over 9.6M votes for each; broker non-votes of 1.77M.","Say-on-pay advisory vote approved: 9,557,433 for, 220,037 against, 107,314 abstain.","Ratification of KPMG LLP as independent auditor for 2026 passed: 11,342,943 for, 205,550 against.","Quorum of 11,651,674 shares represented out of 14,414,482 outstanding shares."],"event_type":"other","confidence":"high","sentiment":"neutral","materiality_score":0.15,"ticker":"TMP","company_name":"TOMPKINS FINANCIAL CORP","filed_at":"2026-05-26T15:06:27+00:00","last_material_update_at":"2026-05-26T15:07:25.328899+00:00","item_codes":["5.07"],"url":"https://secwatch.observer/filing/0001999371-26-011418","json_url":"https://secwatch.observer/filing/0001999371-26-011418.json","markdown_url":"https://secwatch.observer/filing/0001999371-26-011418.md","summary_text_url":"https://secwatch.observer/filing/0001999371-26-011418.txt","source_url":"https://www.sec.gov/Archives/edgar/data/1005817/000199937126011418/0001999371-26-011418-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/1005817/000199937126011418/tmp-8k_051926.htm"},{"accession":"0001213900-26-060879","headline":"Profusa and Bio Insights amend asset purchase agreement; delete provision for 12% management share issuance","bullets":["Amendment removes Section 4.6 requiring issuance of 12% fully diluted shares to CEO and CFO as retention.","$30M purchase price for PanOmics multi-omics assay know-how, paid in Series A Convertible Preferred, unchanged.","Amendment confirms no other changes to the Asset Purchase Agreement remain in full force."],"event_type":"m_and_a","confidence":"high","sentiment":"neutral","materiality_score":0.5,"ticker":"PFSA","company_name":"Profusa, Inc.","filed_at":"2026-05-26T15:05:14+00:00","last_material_update_at":"2026-05-26T15:07:00.627884+00:00","item_codes":["1.01","9.01"],"url":"https://secwatch.observer/filing/0001213900-26-060879","json_url":"https://secwatch.observer/filing/0001213900-26-060879.json","markdown_url":"https://secwatch.observer/filing/0001213900-26-060879.md","summary_text_url":"https://secwatch.observer/filing/0001213900-26-060879.txt","source_url":"https://www.sec.gov/Archives/edgar/data/1859807/000121390026060879/0001213900-26-060879-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/1859807/000121390026060879/ea0292151-8k_profusa.htm"},{"accession":"0001104659-26-066117","headline":"Stone Point Credit Income Fund declares $0.22 monthly distribution for May 2026","bullets":["Distribution of $0.22 per common share declared for May 2026.","Record date: May 31, 2026; payment date: June 20, 2026.","Distribution payable in cash or reinvested under distribution reinvestment plan."],"event_type":"dividend","confidence":"high","sentiment":"neutral","materiality_score":0.25,"ticker":null,"company_name":"Stone Point Credit Income Fund","filed_at":"2026-05-26T15:01:07+00:00","last_material_update_at":"2026-05-26T15:02:21.139800+00:00","item_codes":["8.01"],"url":"https://secwatch.observer/filing/0001104659-26-066117","json_url":"https://secwatch.observer/filing/0001104659-26-066117.json","markdown_url":"https://secwatch.observer/filing/0001104659-26-066117.md","summary_text_url":"https://secwatch.observer/filing/0001104659-26-066117.txt","source_url":"https://www.sec.gov/Archives/edgar/data/2031283/000110465926066117/0001104659-26-066117-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/2031283/000110465926066117/tm2615525d1_8k.htm"},{"accession":"0001193125-26-238237","headline":"Alaunos reports ALN1003 preclinical data: -12.9% weight loss, liver weight -43%; cash only $0.35M","bullets":["ALN1003 in DIO mice: mean body weight change -12.9% by Day 33 and -10.3% by Day 48 (p<0.0001).","Liver weight reduced 43% (p<0.0001); lower ALT, AST, ALP and improved histology in treated animals.","Favorable body composition shift: fat -44.6% (grams), lean +17.2% as % body weight (high dose).","Cash and cash equivalents $0.354M as of March 31, 2026; runway into Q2 2026, needs additional financing.","Data from non-GLP mouse studies only; ALN1003 has not been tested in humans."],"event_type":"other_material","confidence":"high","sentiment":"neutral","materiality_score":0.65,"ticker":"TCRT","company_name":"Alaunos Therapeutics, Inc.","filed_at":"2026-05-26T15:00:21+00:00","last_material_update_at":"2026-05-26T15:02:37.902818+00:00","item_codes":["8.01","9.01"],"url":"https://secwatch.observer/filing/0001193125-26-238237","json_url":"https://secwatch.observer/filing/0001193125-26-238237.json","markdown_url":"https://secwatch.observer/filing/0001193125-26-238237.md","summary_text_url":"https://secwatch.observer/filing/0001193125-26-238237.txt","source_url":"https://www.sec.gov/Archives/edgar/data/1107421/000119312526238237/0001193125-26-238237-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/1107421/000119312526238237/tcrt-20260526.htm"},{"accession":"0001331465-26-000101","headline":"FHLB Atlanta issues $620M in consolidated obligations bonds","bullets":["$350M bond at 3.887%, matures Feb 23, 2027, callable European.","Two $10M bonds at 4.80%, mature May 20, 2031, callable Bermudan.","$250M bond at 3.83%, matures Nov 20, 2026, callable Bermudan.","All bonds are joint and several obligations of the 11 Federal Home Loan Banks."],"event_type":"debt","confidence":"high","sentiment":"neutral","materiality_score":0.5,"ticker":null,"company_name":"Federal Home Loan Bank of Atlanta","filed_at":"2026-05-26T14:52:06+00:00","last_material_update_at":"2026-05-26T15:00:44.557944+00:00","item_codes":["2.03"],"url":"https://secwatch.observer/filing/0001331465-26-000101","json_url":"https://secwatch.observer/filing/0001331465-26-000101.json","markdown_url":"https://secwatch.observer/filing/0001331465-26-000101.md","summary_text_url":"https://secwatch.observer/filing/0001331465-26-000101.txt","source_url":"https://www.sec.gov/Archives/edgar/data/1331465/000133146526000101/0001331465-26-000101-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/1331465/000133146526000101/fhlba-20260520.htm"},{"accession":"0001326771-26-000091","headline":"FHLB Cincinnati issues $575.5M in consolidated bonds across three tranches","bullets":["$46M fixed-rate callable bond at 5.25% maturing June 2036 (CUSIP 3130BAUH8).","$29.5M fixed-rate callable bond at 5.00% maturing June 2033 (CUSIP 3130BAUK1).","$500M non-callable variable-rate floater maturing Jan 2027 (CUSIP 3130BAUS4).","Consolidated Obligations are joint and several obligations of all 11 FHLBs, not U.S. guaranteed."],"event_type":"debt","confidence":"high","sentiment":"neutral","materiality_score":0.5,"ticker":null,"company_name":"Federal Home Loan Bank of Cincinnati","filed_at":"2026-05-26T14:40:01+00:00","last_material_update_at":"2026-05-26T14:41:13.818129+00:00","item_codes":["2.03"],"url":"https://secwatch.observer/filing/0001326771-26-000091","json_url":"https://secwatch.observer/filing/0001326771-26-000091.json","markdown_url":"https://secwatch.observer/filing/0001326771-26-000091.md","summary_text_url":"https://secwatch.observer/filing/0001326771-26-000091.txt","source_url":"https://www.sec.gov/Archives/edgar/data/1326771/000132677126000091/0001326771-26-000091-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/1326771/000132677126000091/fhlbcin-20260520.htm"},{"accession":"0000355811-26-000028","headline":"Gentex annual meeting results: all nine directors elected, EY ratified, compensation and incentive plan approved","bullets":["All nine director nominees elected with votes for ranging from 158M to 172M; broker non-votes ~17.9M.","Ratification of Ernst & Young as auditor for FY2026 approved: 184.0M for, 6.4M against, 158k abstain.","Advisory vote on executive compensation approved: 167.8M for, 4.4M against, 369k abstain.","2026 Omnibus Incentive Plan approved: 149.8M for, 22.6M against, 316k abstain."],"event_type":"other","confidence":"high","sentiment":"neutral","materiality_score":0.2,"ticker":"GNTX","company_name":"GENTEX CORP","filed_at":"2026-05-26T14:26:36+00:00","last_material_update_at":"2026-05-26T14:27:44.788969+00:00","item_codes":["5.07"],"url":"https://secwatch.observer/filing/0000355811-26-000028","json_url":"https://secwatch.observer/filing/0000355811-26-000028.json","markdown_url":"https://secwatch.observer/filing/0000355811-26-000028.md","summary_text_url":"https://secwatch.observer/filing/0000355811-26-000028.txt","source_url":"https://www.sec.gov/Archives/edgar/data/355811/000035581126000028/0000355811-26-000028-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/355811/000035581126000028/gntx-20260521.htm"},{"accession":"0001539497-26-001556","headline":"Structured Obligations Corp reports May 2026 distribution for Select Notes Trust LT 2003-5","bullets":["Total interest distributed: $139,895.78 on 36,170 certificates (principal balance $30,170,000).","Interest income per certificate: $3.058474, interest expense $0.","Advances made to trustee: $41,770.83; net amount owed to advancing party: $408,888.65.","Underlying securities received only one payment: Dow Chemical Co 7.375% coupon $110,625; all others $0."],"event_type":"other_material","confidence":"high","sentiment":"neutral","materiality_score":0.15,"ticker":null,"company_name":"STRUCTURED OBLIGATIONS CORP LONG TERM CERTS SER 2003-5","filed_at":"2026-05-26T14:26:12+00:00","last_material_update_at":"2026-05-26T14:27:56.337353+00:00","item_codes":["8.01","9.01"],"url":"https://secwatch.observer/filing/0001539497-26-001556","json_url":"https://secwatch.observer/filing/0001539497-26-001556.json","markdown_url":"https://secwatch.observer/filing/0001539497-26-001556.md","summary_text_url":"https://secwatch.observer/filing/0001539497-26-001556.txt","source_url":"https://www.sec.gov/Archives/edgar/data/1269371/000153949726001556/0001539497-26-001556-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/1269371/000153949726001556/n5835_x2-8k.htm"},{"accession":"0001539497-26-001555","headline":"Select Notes Trust LT 2003-4 May 2026 distribution: $168,696.63 paid, $37.6M principal outstanding","bullets":["Interest distributed $168,696.63 on $37,627,500 principal (51,127.50 certificates).","Trust received $165,937.50 in interest; advances of $23,593.75 made to cover distribution.","Only Dow Chemical (7.375% 2029) made a payment of $165,937.50; all other underlying securities paid $0.","Net amount owed to Advancing Party at distribution date: $658,575.92."],"event_type":"other","confidence":"high","sentiment":"neutral","materiality_score":0.0,"ticker":null,"company_name":"STRUCTURED OBLIGATIONS CORP LONG TERM CERTS SER 2003-4","filed_at":"2026-05-26T14:25:46+00:00","last_material_update_at":"2026-05-26T14:28:24.470735+00:00","item_codes":["8.01","9.01"],"url":"https://secwatch.observer/filing/0001539497-26-001555","json_url":"https://secwatch.observer/filing/0001539497-26-001555.json","markdown_url":"https://secwatch.observer/filing/0001539497-26-001555.md","summary_text_url":"https://secwatch.observer/filing/0001539497-26-001555.txt","source_url":"https://www.sec.gov/Archives/edgar/data/1264157/000153949726001555/0001539497-26-001555-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/1264157/000153949726001555/n5834_x2-8k.htm"},{"accession":"0001539497-26-001554","headline":"Trustee's May 2026 distribution report for Select Notes Trust LT 2003-3 shows $149,333 interest paid","bullets":["Interest received: $110,625; total distributed: $149,333.32.","Advances made: $51,208.33; net owed to Advancing Party: $470,977.66.","Certificates outstanding: 35,550; principal balance: $32,550,000.","Only Dow Chemical Co paid interest ($110,625) during period; other underlying securities had zero payments."],"event_type":"other_material","confidence":"high","sentiment":"neutral","materiality_score":0.1,"ticker":null,"company_name":"STRUCTURED OBLIGATIONS CORP LONG TERM CERT SER 2003 3","filed_at":"2026-05-26T14:25:15+00:00","last_material_update_at":"2026-05-26T14:27:32.822681+00:00","item_codes":["8.01","9.01"],"url":"https://secwatch.observer/filing/0001539497-26-001554","json_url":"https://secwatch.observer/filing/0001539497-26-001554.json","markdown_url":"https://secwatch.observer/filing/0001539497-26-001554.md","summary_text_url":"https://secwatch.observer/filing/0001539497-26-001554.txt","source_url":"https://www.sec.gov/Archives/edgar/data/1255604/000153949726001554/0001539497-26-001554-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/1255604/000153949726001554/n5833_x2-8k.htm"},{"accession":"0001539497-26-001553","headline":"Trustee reports May 2026 distribution for Select Notes Trust LT 2003-2","bullets":["Total interest received during interest period: $230,625.","Interest distributed to certificateholders: $168,083 (per certificate: $6.63669).","Certificates outstanding: 34,750; no advances made; $50,042 in repayments.","Net amount owed to Advancing Party as of distribution date: $403,085.","Interest payments received on Dow Chemical ($110,625) and GMAC ($120,000) bonds."],"event_type":"other","confidence":"high","sentiment":"neutral","materiality_score":0.1,"ticker":null,"company_name":"STRUCTURED OBLIGATIONS CORP SELECT NOTES TRUST LT SER 2003-2","filed_at":"2026-05-26T14:24:43+00:00","last_material_update_at":"2026-05-26T14:27:18.269459+00:00","item_codes":["8.01","9.01"],"url":"https://secwatch.observer/filing/0001539497-26-001553","json_url":"https://secwatch.observer/filing/0001539497-26-001553.json","markdown_url":"https://secwatch.observer/filing/0001539497-26-001553.md","summary_text_url":"https://secwatch.observer/filing/0001539497-26-001553.txt","source_url":"https://www.sec.gov/Archives/edgar/data/1227090/000153949726001553/0001539497-26-001553-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/1227090/000153949726001553/n5832_x2-8k.htm"},{"accession":"0001539497-26-001552","headline":"Select Notes Trust LT 2003-1: May 2026 distribution report shows $208k interest, zero principal loss","bullets":["Total interest distributed to certificateholders: $208,278.25; per certificate interest income: $3.035953.","Advances of $49,791.67 made to trustee; $0 repaid; net owed to advancing party $760,896.68.","No principal distributions or principal losses; 52,290 certificates outstanding with notional $42,290,000.","Only Target Corp (6.35% 2032) made interest payment of $158,750; nine other underlying securities paid $0."],"event_type":"other_material","confidence":"high","sentiment":"neutral","materiality_score":0.2,"ticker":null,"company_name":"STRUCTURED OBLIGATIONS CORP SELECT NOTES TRUST LT SER 2003-1","filed_at":"2026-05-26T14:24:13+00:00","last_material_update_at":"2026-05-26T14:26:57.623502+00:00","item_codes":["8.01","9.01"],"url":"https://secwatch.observer/filing/0001539497-26-001552","json_url":"https://secwatch.observer/filing/0001539497-26-001552.json","markdown_url":"https://secwatch.observer/filing/0001539497-26-001552.md","summary_text_url":"https://secwatch.observer/filing/0001539497-26-001552.txt","source_url":"https://www.sec.gov/Archives/edgar/data/1223444/000153949726001552/0001539497-26-001552-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/1223444/000153949726001552/n5831_x2-8k.htm"},{"accession":"0001193125-26-238180","headline":"FHLB Pittsburgh issues $3.013B in consolidated obligations on May 20-21, 2026","bullets":["Largest single issuance: $600M non-callable floater (CUSIP 3130BAUM7) settling May 21, maturing Dec 22, 2026.","Issues include fixed-rate (3.875% to 5%) bonds and single-index floaters, maturities from 6 months to 5 years.","Callable bonds (Bermudan/European) total ~$680M; non-callable bonds total ~$2.333B.","Obligations are joint and several among all 11 Federal Home Loan Banks, not guaranteed by U.S. government.","Issuance is part of regular funding operations; proceeds used for general corporate purposes."],"event_type":"debt","confidence":"high","sentiment":"neutral","materiality_score":0.5,"ticker":null,"company_name":"Federal Home Loan Bank of Pittsburgh","filed_at":"2026-05-26T14:07:41+00:00","last_material_update_at":"2026-05-26T14:09:26.242832+00:00","item_codes":["2.03","9.01"],"url":"https://secwatch.observer/filing/0001193125-26-238180","json_url":"https://secwatch.observer/filing/0001193125-26-238180.json","markdown_url":"https://secwatch.observer/filing/0001193125-26-238180.md","summary_text_url":"https://secwatch.observer/filing/0001193125-26-238180.txt","source_url":"https://www.sec.gov/Archives/edgar/data/1330399/000119312526238180/0001193125-26-238180-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/1330399/000119312526238180/ck0001330399-20260520.htm"},{"accession":"0001213900-26-060830","headline":"Ionetix receives FDA approval for Gallium Ga-68 gozetotide (PSMA-11) ANDA","bullets":["FDA approved Ionetix's Abbreviated New Drug Application for Gallium Ga-68 gozetotide, a PET diagnostic agent.","First commercial drug manufacturer to receive ANDA approval for this drug.","Indicated for PSMA-PET imaging to detect prostate cancer lesions in men with suspected metastasis or recurrence.","Product supplied as single-dose capped syringe (~8-10mL) with three-hour expiration from end of synthesis.","Expands Ionetix's portfolio in PET diagnostics; company plans to serve underserved areas via existing multi-site PET facility network."],"event_type":"regulatory","confidence":"high","sentiment":"positive","materiality_score":0.7,"ticker":null,"company_name":"Ionetix Corp / DE /","filed_at":"2026-05-26T14:00:15+00:00","last_material_update_at":"2026-05-26T14:01:20.014674+00:00","item_codes":["7.01","9.01"],"url":"https://secwatch.observer/filing/0001213900-26-060830","json_url":"https://secwatch.observer/filing/0001213900-26-060830.json","markdown_url":"https://secwatch.observer/filing/0001213900-26-060830.md","summary_text_url":"https://secwatch.observer/filing/0001213900-26-060830.txt","source_url":"https://www.sec.gov/Archives/edgar/data/2108121/000121390026060830/0001213900-26-060830-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/2108121/000121390026060830/ea0292072-8k_ionetix.htm"},{"accession":"0001331754-26-000119","headline":"FHLBank Indianapolis issues $100M in callable consolidated bonds with fixed rates","bullets":["Issued four fixed-rate callable bonds totaling $100M par value on May 20, 2026.","Bonds have coupons 4.580%-5.750%, settlement dates June 4-10, 2026.","Maturities range from June 2030 to June 2041; callable annually from June 2027.","Bonds are joint & several obligations of all FHLBanks, not guaranteed by U.S. government."],"event_type":"debt","confidence":"high","sentiment":"neutral","materiality_score":0.25,"ticker":null,"company_name":"Federal Home Loan Bank of Indianapolis","filed_at":"2026-05-26T13:42:24+00:00","last_material_update_at":"2026-05-26T13:43:25.306822+00:00","item_codes":["2.03"],"url":"https://secwatch.observer/filing/0001331754-26-000119","json_url":"https://secwatch.observer/filing/0001331754-26-000119.json","markdown_url":"https://secwatch.observer/filing/0001331754-26-000119.md","summary_text_url":"https://secwatch.observer/filing/0001331754-26-000119.txt","source_url":"https://www.sec.gov/Archives/edgar/data/1331754/000133175426000119/0001331754-26-000119-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/1331754/000133175426000119/fhlbi-20260520.htm"},{"accession":"0001104659-26-066072","headline":"Director Daniel J. Roller resigns from Pure Cycle board effective May 21, 2026","bullets":["Daniel J. Roller notified the board of his resignation, effective immediately on May 21, 2026.","Resignation did not result from any disagreement with the company on operations, policies, or practices.","No replacement director has been named as of the filing date."],"event_type":"leadership","confidence":"high","sentiment":"neutral","materiality_score":0.25,"ticker":"PCYO","company_name":"PURE CYCLE CORP","filed_at":"2026-05-26T13:34:50+00:00","last_material_update_at":"2026-05-26T13:36:17.955492+00:00","item_codes":["5.02"],"url":"https://secwatch.observer/filing/0001104659-26-066072","json_url":"https://secwatch.observer/filing/0001104659-26-066072.json","markdown_url":"https://secwatch.observer/filing/0001104659-26-066072.md","summary_text_url":"https://secwatch.observer/filing/0001104659-26-066072.txt","source_url":"https://www.sec.gov/Archives/edgar/data/276720/000110465926066072/0001104659-26-066072-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/276720/000110465926066072/pcyo-20260521x8k.htm"},{"accession":"0001437749-26-018323","headline":"MainStreet Bancshares repurchases 207,000 shares at avg $24.09 since Q2 start","bullets":["Repurchased 207,000 common shares since Q2 2026 start at avg price $24.09 per share.","Tangible book value at March 31, 2025 was $25.63; repurchase price below book value.","Buybacks made under existing program; no obligation to continue; program may be suspended.","Shares repurchased in compliance with Rule 10b-18 and legal requirements."],"event_type":"other_material","confidence":"high","sentiment":"positive","materiality_score":0.5,"ticker":"MNSB","company_name":"MainStreet Bancshares, Inc.","filed_at":"2026-05-26T13:30:02+00:00","last_material_update_at":"2026-05-26T13:33:19.632676+00:00","item_codes":["8.01"],"url":"https://secwatch.observer/filing/0001437749-26-018323","json_url":"https://secwatch.observer/filing/0001437749-26-018323.json","markdown_url":"https://secwatch.observer/filing/0001437749-26-018323.md","summary_text_url":"https://secwatch.observer/filing/0001437749-26-018323.txt","source_url":"https://www.sec.gov/Archives/edgar/data/1693577/000143774926018323/0001437749-26-018323-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/1693577/000143774926018323/main20260521_8k.htm"},{"accession":"0001104659-26-066062","headline":"Gain Therapeutics reports Phase 1b extension: GluSph down 81%, 4.8-pt MDS-UPDRS difference","bullets":["16 of 19 Part 1 participants continued into 9-month extension; all 16 remain on study at Day 150.","In participants with elevated baseline CSF GluSph, levels dropped an average of 81% after 90 days.","At Day 150, high-baseline GluSph group showed 4.8-point greater improvement in MDS-UPDRS Parts II+III vs low-baseline group.","Unsolicited patient reports: improved smell/taste (4), balance/gait (4), and sleep (3) after 90 days.","Planned Phase 2 will add UPSIT smell test and Opal wearable gait assessments as endpoints."],"event_type":"other_material","confidence":"high","sentiment":"positive","materiality_score":0.75,"ticker":"GANX","company_name":"Gain Therapeutics, Inc.","filed_at":"2026-05-26T13:26:00+00:00","last_material_update_at":"2026-05-26T13:27:43.981584+00:00","item_codes":["8.01"],"url":"https://secwatch.observer/filing/0001104659-26-066062","json_url":"https://secwatch.observer/filing/0001104659-26-066062.json","markdown_url":"https://secwatch.observer/filing/0001104659-26-066062.md","summary_text_url":"https://secwatch.observer/filing/0001104659-26-066062.txt","source_url":"https://www.sec.gov/Archives/edgar/data/1819411/000110465926066062/0001104659-26-066062-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/1819411/000110465926066062/tm2615594d1_8k.htm"},{"accession":"0001683168-26-004287","headline":"iPower activates trading plan for $2M share repurchase; first funding tranche this week","bullets":["iPower executed documents to implement a trading plan for its previously authorized $2M share repurchase program.","Trading plan expected to become active after broker execution and regulatory steps; first tranche funding planned this week.","The program does not obligate iPower to acquire any specific number of shares and may be suspended or discontinued at any time."],"event_type":"other_material","confidence":"high","sentiment":"neutral","materiality_score":0.4,"ticker":"IPW","company_name":"iPower Inc.","filed_at":"2026-05-26T13:20:16+00:00","last_material_update_at":"2026-05-26T13:22:50.372373+00:00","item_codes":["8.01","9.01"],"url":"https://secwatch.observer/filing/0001683168-26-004287","json_url":"https://secwatch.observer/filing/0001683168-26-004287.json","markdown_url":"https://secwatch.observer/filing/0001683168-26-004287.md","summary_text_url":"https://secwatch.observer/filing/0001683168-26-004287.txt","source_url":"https://www.sec.gov/Archives/edgar/data/1830072/000168316826004287/0001683168-26-004287-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/1830072/000168316826004287/ipower_8k.htm"},{"accession":"0000354950-26-000105","headline":"Home Depot shareholders approve charter amendments adding officer exculpation, elect all directors","bullets":["Amendment to Charter eliminates monetary liability of certain officers under Delaware law, effective May 21, 2026.","All 12 director nominees elected, including CEO Edward P. Decker (677M votes for).","KPMG LLP ratified as independent auditor for FY ending Jan 31, 2027 (801M for, 47.5M against).","Advisory say-on-pay approved with 671M votes for; nine shareholder proposals all defeated."],"event_type":"other_material","confidence":"high","sentiment":"neutral","materiality_score":0.4,"ticker":"HD","company_name":"HOME DEPOT, INC.","filed_at":"2026-05-26T13:19:39+00:00","last_material_update_at":"2026-05-26T13:22:03.718704+00:00","item_codes":["5.03","5.07","9.01"],"url":"https://secwatch.observer/filing/0000354950-26-000105","json_url":"https://secwatch.observer/filing/0000354950-26-000105.json","markdown_url":"https://secwatch.observer/filing/0000354950-26-000105.md","summary_text_url":"https://secwatch.observer/filing/0000354950-26-000105.txt","source_url":"https://www.sec.gov/Archives/edgar/data/354950/000035495026000105/0000354950-26-000105-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/354950/000035495026000105/hd-20260521.htm"},{"accession":"0001822928-26-000052","headline":"Holley announces $25M share repurchase program; reaffirms net leverage target","bullets":["Board authorized repurchase of up to $25M of common stock; no time limit or minimum obligation.","CEO cites $100M debt reduction, margin expansion, and portfolio repositioning behind program.","Company reaffirms commitment to year-end net leverage below 3.5x.","Repurchases will be opportunistic, funded by free cash flow, in compliance with Rule 10b-18.","Program completes three-pronged capital allocation: debt reduction, M&A, and share repurchases."],"event_type":"other_material","confidence":"high","sentiment":"positive","materiality_score":0.6,"ticker":"HLLY","company_name":"Holley Inc.","filed_at":"2026-05-26T13:17:07+00:00","last_material_update_at":"2026-05-26T13:19:10.981484+00:00","item_codes":["8.01","9.01"],"url":"https://secwatch.observer/filing/0001822928-26-000052","json_url":"https://secwatch.observer/filing/0001822928-26-000052.json","markdown_url":"https://secwatch.observer/filing/0001822928-26-000052.md","summary_text_url":"https://secwatch.observer/filing/0001822928-26-000052.txt","source_url":"https://www.sec.gov/Archives/edgar/data/1822928/000182292826000052/0001822928-26-000052-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/1822928/000182292826000052/hlly-20260522.htm"},{"accession":"0001467623-26-000034","headline":"Dropbox appoints Ashraf Alkarmi as co-CEO; Drew Houston to become Executive Chairman; Q2/FY26 guidance reaffirmed","bullets":["Ashraf Alkarmi, previously GM Core, appointed co-CEO effective May 26, 2026; will become sole CEO after transition; Drew Houston to become Executive Chairman.","Alkarmi receives $825k base salary, 100% target bonus, and RSUs valued at $12.656M vesting over four years.","Michael Torres appointed Chief Product Officer effective July 7, 2026; previously VP Product at Alphabet/Chrome and VP/GM Kindle at Amazon.","Company expects Q2 and full-year 2026 results to be in-line or above previously provided guidance ranges."],"event_type":"leadership","confidence":"high","sentiment":"neutral","materiality_score":0.8,"ticker":"DBX","company_name":"DROPBOX, INC.","filed_at":"2026-05-26T13:15:23+00:00","last_material_update_at":"2026-05-26T13:22:25.260140+00:00","item_codes":["5.02","7.01","9.01"],"url":"https://secwatch.observer/filing/0001467623-26-000034","json_url":"https://secwatch.observer/filing/0001467623-26-000034.json","markdown_url":"https://secwatch.observer/filing/0001467623-26-000034.md","summary_text_url":"https://secwatch.observer/filing/0001467623-26-000034.txt","source_url":"https://www.sec.gov/Archives/edgar/data/1467623/000146762326000034/0001467623-26-000034-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/1467623/000146762326000034/dbx-20260521.htm"},{"accession":"0001551306-26-000074","headline":"Progyny board approves $200M share repurchase program","bullets":["Board authorized repurchase of up to $200M of common stock, funded from available cash balances.","Repurchases may be made through open market transactions or Rule 10b5-1 plans.","Program may be suspended or discontinued at any time; no assurance on number or prices."],"event_type":"other_material","confidence":"high","sentiment":"positive","materiality_score":0.55,"ticker":"PGNY","company_name":"Progyny, Inc.","filed_at":"2026-05-26T13:15:09+00:00","last_material_update_at":"2026-05-26T13:24:14.545076+00:00","item_codes":["8.01"],"url":"https://secwatch.observer/filing/0001551306-26-000074","json_url":"https://secwatch.observer/filing/0001551306-26-000074.json","markdown_url":"https://secwatch.observer/filing/0001551306-26-000074.md","summary_text_url":"https://secwatch.observer/filing/0001551306-26-000074.txt","source_url":"https://www.sec.gov/Archives/edgar/data/1551306/000155130626000074/0001551306-26-000074-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/1551306/000155130626000074/pgny-20260526.htm"},{"accession":"0000884614-26-000037","headline":"UGI's AmeriGas unit issues $500M 6.875% notes, tenders for 2028 notes, redeems 2027 notes","bullets":["Issued $500M 6.875% senior notes due 2031; proceeds to redeem 2027 notes and tender up to $175M of 2028 notes.","Redeemed $468.47M of 5.75% 2027 notes at $1,011.18 per $1,000; full redemption on June 10, 2026.","Early tender results: $224.77M of 9.375% 2028 notes tendered; $175M accepted at 77.9% pro-rata; payment May 27.","Use of proceeds also includes repaying $150M intercompany loan to UGI International."],"event_type":"debt","confidence":"high","sentiment":"neutral","materiality_score":0.65,"ticker":"UGI","company_name":"UGI CORP /PA/","filed_at":"2026-05-26T13:03:53+00:00","last_material_update_at":"2026-05-26T13:07:27.672562+00:00","item_codes":["1.01","1.02","2.03","8.01","9.01"],"url":"https://secwatch.observer/filing/0000884614-26-000037","json_url":"https://secwatch.observer/filing/0000884614-26-000037.json","markdown_url":"https://secwatch.observer/filing/0000884614-26-000037.md","summary_text_url":"https://secwatch.observer/filing/0000884614-26-000037.txt","source_url":"https://www.sec.gov/Archives/edgar/data/884614/000088461426000037/0000884614-26-000037-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/884614/000088461426000037/ugi-20260520.htm"},{"accession":"0000926617-26-000037","headline":"Aspira Women's Health enters collaboration with Cleveland Clinic for AI-powered diagnostics","bullets":["Partnering fee of $125,000; $50,000 due within 30 days, then $25,000 on each of first three anniversaries.","Collaboration focuses on biomarker discovery, AI-driven modeling, and clinical validation for women's health diagnostics.","Joint leadership: Dr. Kevin Elias (Cleveland Clinic) and Dr. Todd Pappas (Aspira) will lead multidisciplinary teams.","Initial five-year term; may be extended by mutual agreement; either party can terminate with 60 days' notice."],"event_type":"other_material","confidence":"high","sentiment":"positive","materiality_score":0.45,"ticker":"AWHL","company_name":"Aspira Women's Health Inc.","filed_at":"2026-05-26T13:03:51+00:00","last_material_update_at":"2026-05-26T13:06:01.515470+00:00","item_codes":["1.01","9.01"],"url":"https://secwatch.observer/filing/0000926617-26-000037","json_url":"https://secwatch.observer/filing/0000926617-26-000037.json","markdown_url":"https://secwatch.observer/filing/0000926617-26-000037.md","summary_text_url":"https://secwatch.observer/filing/0000926617-26-000037.txt","source_url":"https://www.sec.gov/Archives/edgar/data/926617/000092661726000037/0000926617-26-000037-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/926617/000092661726000037/awhl-20260520x8k.htm"},{"accession":"0001051512-26-000049","headline":"TDS shareholders elect directors, approve auditor and officer exculpation charter amendment","bullets":["All eight Series A directors (Carlson Jr., Carlson M.D., Carlson P., Carlson W., Dixon K.S., Off, Rutledge, Villacrez) elected with ~74.8M votes each.","Common share directors: K. Dixon, O'Leary, Oosterman, Woessner elected; O'Leary received 57.9M for, 36.2M withhold.","Ratification of PwC as auditor for 2026 approved: 127.5M for, 517K against.","Amendment to certificate to permit officer exculpation approved: 110.2M for, 13.7M against.","Advisory say-on-pay passed: 118.8M for, 6.6M against."],"event_type":"other","confidence":"high","sentiment":"neutral","materiality_score":0.1,"ticker":"TDS","company_name":"TELEPHONE & DATA SYSTEMS INC /DE/","filed_at":"2026-05-26T13:02:17+00:00","last_material_update_at":"2026-05-26T13:05:07.795185+00:00","item_codes":["5.07"],"url":"https://secwatch.observer/filing/0001051512-26-000049","json_url":"https://secwatch.observer/filing/0001051512-26-000049.json","markdown_url":"https://secwatch.observer/filing/0001051512-26-000049.md","summary_text_url":"https://secwatch.observer/filing/0001051512-26-000049.txt","source_url":"https://www.sec.gov/Archives/edgar/data/1051512/000105151226000049/0001051512-26-000049-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/1051512/000105151226000049/tds-20260521.htm"},{"accession":"0001639825-26-000024","headline":"Peloton appoints Sid Thacker as CFO effective June 22, 2026; Saqib Baig remains CAO","bullets":["Sid Thacker named CFO effective June 22, 2026; succeeds interim CFO Saqib Baig who stays CAO.","Thacker previously CFO of Rent the Runway (May 2023–June 2026); led financial transformation.","Compensation: $635k base salary, 60% bonus target, equity awards initially valued at $8M.","Thacker to oversee global finance and corporate strategy; report to CEO Peter Stern."],"event_type":"leadership","confidence":"high","sentiment":"neutral","materiality_score":0.7,"ticker":"PTON","company_name":"PELOTON INTERACTIVE, INC.","filed_at":"2026-05-26T13:01:40+00:00","last_material_update_at":"2026-05-26T13:05:14.974245+00:00","item_codes":["5.02","7.01","9.01"],"url":"https://secwatch.observer/filing/0001639825-26-000024","json_url":"https://secwatch.observer/filing/0001639825-26-000024.json","markdown_url":"https://secwatch.observer/filing/0001639825-26-000024.md","summary_text_url":"https://secwatch.observer/filing/0001639825-26-000024.txt","source_url":"https://www.sec.gov/Archives/edgar/data/1639825/000163982526000024/0001639825-26-000024-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/1639825/000163982526000024/pton-20260521.htm"},{"accession":"0001193125-26-238061","headline":"NFG files financials for $2.62B CenterPoint Ohio acquisition; close expected Q4 2026","bullets":["Purchase price $2.62B: $1.42B cash at close + $1.2B 364-day seller promissory note.","Transaction expected to close Q4 2026; cannot close before Oct 1, 2026 without seller consent.","Conditions include HSR antitrust review expiration and PUCO approval.","CenterPoint Ohio serves ~337,000 customers via 6,000 miles of pipeline in Ohio.","Target reported FY2025 net income of $68M and revenue of $268M; audited and pro forma statements filed."],"event_type":"m_and_a","confidence":"high","sentiment":"neutral","materiality_score":0.75,"ticker":"NFG","company_name":"NATIONAL FUEL GAS CO","filed_at":"2026-05-26T12:56:44+00:00","last_material_update_at":"2026-05-26T13:00:07.526727+00:00","item_codes":["8.01","9.01"],"url":"https://secwatch.observer/filing/0001193125-26-238061","json_url":"https://secwatch.observer/filing/0001193125-26-238061.json","markdown_url":"https://secwatch.observer/filing/0001193125-26-238061.md","summary_text_url":"https://secwatch.observer/filing/0001193125-26-238061.txt","source_url":"https://www.sec.gov/Archives/edgar/data/70145/000119312526238061/0001193125-26-238061-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/70145/000119312526238061/d90390d8k.htm"},{"accession":"0001193125-26-238059","headline":"Corbus reports CRB-701 42.9% cORR in 2L OPSCC at 3.6 mg/kg; registrational study planned summer 2026","bullets":["cORR 42.9% (9/21) in 2L OPSCC at 3.6 mg/kg; median DOR 6.3 mo, PFS 5.6 mo.","cORR 34.4% (11/32) in 2L cervical cancer at 3.6 mg/kg; 2 complete responses, DOR 8.0 mo.","Safety: treatment discontinuations 2.8%; no Grade 5 events; ocular AEs manageable.","FDA alignment on registrational trials: TEMPO-1 (OPSCC, n=250) to start summer 2026.","85.4% of OPSCC patients HPV+; 8 of 9 responders in OPSCC were HPV+."],"event_type":"other_material","confidence":"high","sentiment":"positive","materiality_score":0.85,"ticker":"CRBP","company_name":"Corbus Pharmaceuticals Holdings, Inc.","filed_at":"2026-05-26T12:56:06+00:00","last_material_update_at":"2026-05-26T13:00:18.417122+00:00","item_codes":["7.01","8.01","9.01"],"url":"https://secwatch.observer/filing/0001193125-26-238059","json_url":"https://secwatch.observer/filing/0001193125-26-238059.json","markdown_url":"https://secwatch.observer/filing/0001193125-26-238059.md","summary_text_url":"https://secwatch.observer/filing/0001193125-26-238059.txt","source_url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312526238059/0001193125-26-238059-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312526238059/crbp-20260526.htm"},{"accession":"0001178913-26-002900","headline":"Silexion Therapeutics announces 1-for-10 reverse share split to maintain Nasdaq listing","bullets":["Reverse share split at 1:10 ratio; effective after market close May 28, 2026; split-adjusted trading begins May 29, 2026.","Ticker remains SLXN; new CUSIP assigned; par value increases from $0.0135 to $0.135 per share.","No fractional shares issued; DTC participants' fractional shares rounded up to nearest whole share.","Split intended to maintain Nasdaq minimum bid price compliance (Rule 5550(a)(2)) and support equity financings."],"event_type":"other_material","confidence":"high","sentiment":"neutral","materiality_score":0.6,"ticker":"SLXN","company_name":"Silexion Therapeutics Corp","filed_at":"2026-05-26T12:48:49+00:00","last_material_update_at":"2026-05-26T12:50:27.315562+00:00","item_codes":["8.01","9.01"],"url":"https://secwatch.observer/filing/0001178913-26-002900","json_url":"https://secwatch.observer/filing/0001178913-26-002900.json","markdown_url":"https://secwatch.observer/filing/0001178913-26-002900.md","summary_text_url":"https://secwatch.observer/filing/0001178913-26-002900.txt","source_url":"https://www.sec.gov/Archives/edgar/data/2022416/000117891326002900/0001178913-26-002900-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/2022416/000117891326002900/zk2635400.htm"},{"accession":"0001683168-26-004286","headline":"Nocera enters $100M equity purchase facility; amends existing SPA","bullets":["Secures up to $100M equity purchase facility with institutional investor over 24 months.","Ownership capped at 4.99% (may increase to 9.99% with 61-day notice); exchange cap of 19.99% without shareholder approval.","Registration Rights Agreement requires initial registration statement filing within 45 days; use best efforts to make effective within 90 days.","First Amendment to Oct 2025 SPA allows proceeds from Additional Closings to be used for general corporate purposes, acquisitions, etc.","Curvature Securities LLC acts as placement agent; shares offered under Section 4(a)(2) exemption."],"event_type":"other_material","confidence":"high","sentiment":"neutral","materiality_score":0.8,"ticker":"NCRA","company_name":"NOCERA, INC.","filed_at":"2026-05-26T12:45:59+00:00","last_material_update_at":"2026-05-26T12:50:36.280970+00:00","item_codes":["1.01","3.02","9.01"],"url":"https://secwatch.observer/filing/0001683168-26-004286","json_url":"https://secwatch.observer/filing/0001683168-26-004286.json","markdown_url":"https://secwatch.observer/filing/0001683168-26-004286.md","summary_text_url":"https://secwatch.observer/filing/0001683168-26-004286.txt","source_url":"https://www.sec.gov/Archives/edgar/data/1756180/000168316826004286/0001683168-26-004286-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/1756180/000168316826004286/nocera_8k.htm"},{"accession":"0001493152-26-025174","headline":"Bitmine ETH holdings reach 5.39M tokens (4.47% supply); total crypto+cash $12.3B","bullets":["5,390,404 ETH held (value $11.5B at $2,134/ETH); also 203 BTC, $200M Beast Industries, $95M Eightco (ORBS), $444M cash.","Total crypto + cash + moonshots = $12.3B; staked ETH 4,712,917 ($10.1B), projected annual staking reward $276M at 2.75% yield.","Acquired 111,942 ETH in past week; Chairman Tom Lee expects to reach 5% of ETH supply during 2026.","Uplisted from NYSE American to NYSE on April 9, 2026; daily trading volume $572M (5-day avg), ranked #193 in US.","Institutional investors include ARK Cathie Wood, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital."],"event_type":"other_material","confidence":"high","sentiment":"positive","materiality_score":0.75,"ticker":"BMNR","company_name":"BITMINE IMMERSION TECHNOLOGIES, INC.","filed_at":"2026-05-26T12:45:25+00:00","last_material_update_at":"2026-05-26T12:50:37.774509+00:00","item_codes":["7.01","9.01"],"url":"https://secwatch.observer/filing/0001493152-26-025174","json_url":"https://secwatch.observer/filing/0001493152-26-025174.json","markdown_url":"https://secwatch.observer/filing/0001493152-26-025174.md","summary_text_url":"https://secwatch.observer/filing/0001493152-26-025174.txt","source_url":"https://www.sec.gov/Archives/edgar/data/1829311/000149315226025174/0001493152-26-025174-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/1829311/000149315226025174/form8-k.htm"},{"accession":"0000064040-26-000031","headline":"S&P Global Market Intelligence President Saugata Saha to depart July 30, 2026; guidance reaffirmed","bullets":["Saugata Saha, President of Market Intelligence and Chief Enterprise Data Officer, leaving effective July 30, 2026.","Enterprise Data Organization moves under Chief Technology & Transformation Officer Firdaus Bhathena.","No successor named for Market Intelligence; CEO says evaluation of leadership and structure is underway.","Company reiterates 2026 financial guidance; no change to outlook.","Saha will remain through July 30 to support transition."],"event_type":"leadership","confidence":"high","sentiment":"neutral","materiality_score":0.55,"ticker":"SPGI","company_name":"S&P Global Inc.","filed_at":"2026-05-26T12:45:08+00:00","last_material_update_at":"2026-05-26T12:51:05.086343+00:00","item_codes":["5.02","7.01","9.01"],"url":"https://secwatch.observer/filing/0000064040-26-000031","json_url":"https://secwatch.observer/filing/0000064040-26-000031.json","markdown_url":"https://secwatch.observer/filing/0000064040-26-000031.md","summary_text_url":"https://secwatch.observer/filing/0000064040-26-000031.txt","source_url":"https://www.sec.gov/Archives/edgar/data/64040/000006404026000031/0000064040-26-000031-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/64040/000006404026000031/spgi-20260519.htm"},{"accession":"0001493152-26-025170","headline":"QHSLab reports April 2026 unaudited revenue of $325,889, up 57% YoY; launches QHS Practice Access Network","bullets":["Unaudited April 2026 revenue $325,889, up 57% from $207,538 in April 2025.","Launches QHS Practice Access Network (PAN), independent rep initiative to accelerate Q-Connect adoption.","Plans to present at Planet MicroCap Showcase June 16-18, 2026 to increase investor visibility.","Recurring revenue focus through practice activation and Q-Connect platform expansion."],"event_type":"other_material","confidence":"high","sentiment":"positive","materiality_score":0.6,"ticker":"USAQ","company_name":"QHSLab, Inc.","filed_at":"2026-05-26T12:30:22+00:00","last_material_update_at":"2026-05-26T12:35:36.695496+00:00","item_codes":["7.01","9.01"],"url":"https://secwatch.observer/filing/0001493152-26-025170","json_url":"https://secwatch.observer/filing/0001493152-26-025170.json","markdown_url":"https://secwatch.observer/filing/0001493152-26-025170.md","summary_text_url":"https://secwatch.observer/filing/0001493152-26-025170.txt","source_url":"https://www.sec.gov/Archives/edgar/data/856984/000149315226025170/0001493152-26-025170-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/856984/000149315226025170/form8-k.htm"},{"accession":"0001493152-26-025171","headline":"Microbot Medical receives Israeli regulatory approval for LIBERTY System, first outside U.S.","bullets":["Israeli Ministry of Health's AMAR Division grants marketing clearance for LIBERTY Endovascular Robotic System in Israel.","First regulatory approval outside the U.S.; enables Free Sale Certificate for submissions in other jurisdictions.","Company targets CE Mark certification by end of 2026 for EU market expansion.","System adopted by multiple U.S. accounts in GA, FL, NY, MA, MI, NC.","Advanced discussions underway to expedite commercialization in Israel."],"event_type":"regulatory","confidence":"high","sentiment":"positive","materiality_score":0.7,"ticker":"MBOT","company_name":"Microbot Medical Inc.","filed_at":"2026-05-26T12:30:22+00:00","last_material_update_at":"2026-05-26T12:35:18.868478+00:00","item_codes":["7.01","8.01","9.01"],"url":"https://secwatch.observer/filing/0001493152-26-025171","json_url":"https://secwatch.observer/filing/0001493152-26-025171.json","markdown_url":"https://secwatch.observer/filing/0001493152-26-025171.md","summary_text_url":"https://secwatch.observer/filing/0001493152-26-025171.txt","source_url":"https://www.sec.gov/Archives/edgar/data/883975/000149315226025171/0001493152-26-025171-index.htm","primary_doc_url":"https://www.sec.gov/Archives/edgar/data/883975/000149315226025171/form8-k.htm"}]}